Guiyang Xintian Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Guiyang Xintian Pharmaceutical Co., Ltd. was founded in August 1995 and listed on the Small and Medium Enterprise Board of the Shenzhen Stock Exchange on May 19, 2017. Its stock name is Xintian Pharmaceutical and its stock code is 002873. The company belongs to the production industry of traditional Chinese patent medicines and simple preparations in the pharmaceutical manufacturing industry. It has eight dosage form production lines of hard capsules, mixtures, granules, gel, tablets, syrups, liquors, and lotions certified by GMP, as well as two production lines of Chinese herbal pieces, Line A and Line B. It is mainly engaged in the research, development, production and sales of traditional Chinese patent medicines and simple preparations products used for diseases of the urinary system, gynecology and other diseases with complex causes to provide safe and effective products for patients. |
| Headquarter | Guiyang |
| Establish Date | 8/11/1995 |
| Listed Code | 002873.SZ |
| Listed Date | 5/19/2017 |
| Chairman | Dong Dalun. |
| CEO | Dong Dalun. |
| Website | www.gyxtyy.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
